Recent evidence has identified distinct stages of AD development, from: early amyloid‐β (Aβ) deposition, tau hyperphosphorylation, release of pro‐inflammatory cytokines, reactive gliosis, demyelination, synaptic loss, metabolic changes, and ultimately neurodegeneration (De Strooper & Karran, 2016). Here, MAPT is linked to Alzheimer disease.